2022 American Transplant Congress
De-Novo Belatacept Therapy is Associated with Higher Levels of BK Viremia and Lower Rates of BK Clearance in Kidney Transplantation Patients
*Purpose: To compare the incidence and severity of BK viremia in kidney transplantation patients with a de-novo belatacept (bela) vs. a no-bela maintenance immunosuppression regimen.*Methods:…2022 American Transplant Congress
Comparison of Outcomes and Management of COVID Infection Among Kidney Transplant Recipients Between Pre-Vaccination Rollout Era and Post-Vaccination Rollout Era
*Purpose: The COVID pandemic has posed a significant challenge among kidney transplant recipients (KTR) due to their immunocompromised states. The effects of COVID vaccination on…2022 American Transplant Congress
A Nationwide, Multi-Center Survey of Lipid Management Strategies in Kidney Transplant Recipients
Renal division, Brigham and Women's Hospital, Boston, MA
*Purpose: KDIGO 2013 guidelines for the management of lipid transplant recommend the use of statins in all kidney transplant recipients (KTRs), but with weak evidence…2022 American Transplant Congress
Direct Health Care Costs Before and After Kidney Transplantation in Germany – A Longitudinal Analysis Based on Claims Data
*Purpose: Kidney transplantation can improve long-term survival and quality of life in transplant candidates with end-stage renal disease and has shown to have long-term economic…2022 American Transplant Congress
Attitudes Regarding COVID-19 Vaccine and Vaccine Hesitancy in an Inner-City Kidney Transplant Recipients (KTRs)
SUNY Downstate Health Sciences University, Brooklyn, NY
*Purpose: KTRs comprise a high-risk group for COVID-19 infection due to comorbidities and immunosuppression. Studying how vaccination hesitancy in inner-city KTRs has changed since the…2022 American Transplant Congress
Impact of the Second Year COVID-19 Pandemic on the U.S. Kidney Transplantation: Interrupted Time Series Analysis
*Purpose: The number of kidney transplant (KT) was decreased since the COVID-19 pandemic; however, the magnitude of the pandemic on the number of U.S. KT…2022 American Transplant Congress
No Difference in Graft Survival Among Low Socioeconomic Kidney Allograft Recipients
*Purpose: Low socioeconomic status remains a barrier in access and equity in kidney transplantation with limited data assessing post-transplant outcomes. Alternative options to transplantation include…2022 American Transplant Congress
Kidney Transplant Professionals’, Recipients’ and Caregivers’ Perspectives on the Use of Precision Medicine in Kidney Transplantation
*Purpose: Kidney transplantation is the optimal treatment for end-stage kidney disease. However, antibody-mediated rejection can lead to graft loss. The use of Precision Medicine (PM)…2022 American Transplant Congress
Variability of Serum Klotho and FGF-23 Levels During the First Two Years After Kidney Transplantation
*Purpose: Klotho is a protein produced in renal tubular cells with nephroprotective actions which acts as a co-receptor for phosphaturic factor FGF-23. The natural history…2022 American Transplant Congress
Streamlining Donation Transplantation Communication Via HIPAA-compliant App
Transplant Connect, Los Angeles, CA
*Purpose: Communication across the donation transplantation ecosystem is fractured and ineffectual, often necessitating the use of unsecured methods such as texting in order to accomplish…
American Transplant Congress abstracts